RUNDC1 Antikörper (C-Term)
Kurzübersicht für RUNDC1 Antikörper (C-Term) (ABIN954643)
Target
Alle RUNDC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 508-537, C-Term
-
Spezifität
- Recognizes RUNDC1 (C-term).
-
Aufreinigung
- Protein A column followed by peptide Affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 508-537 amino acids from the C-terminal region of Human RUNDC1 Genename: RUNDC1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- RUNDC1 (RUN Domain Containing 1 (RUNDC1))
-
Andere Bezeichnung
- RUNDC1
-
Hintergrund
- RUNDC1 may play a role as p53/TP53 inhibitor and thus may have oncogenic activity.Synonyms: LP5161, RUN domain-containing protein 1
-
Gen-ID
- 146923
-
NCBI Accession
- NP_775102
Target
-